Next Article in Journal
Viral Particle-Mediated SAMHD1 Depletion Sensitizes Refractory Glioblastoma to DNA-Damaging Therapeutics by Impairing Homologous Recombination
Next Article in Special Issue
Ixazomib, Lenalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma in Routine Clinical Practice: Extended Follow-Up Analysis and the Results of Subsequent Therapy
Previous Article in Journal
Concomitant Inhibition of FASN and SREBP Provides a Promising Therapy for CTCL
 
 
Review

Article Versions Notes

Cancers 2022, 14(18), 4492; https://doi.org/10.3390/cancers14184492
Action Date Notes Link
article xml file uploaded 16 September 2022 11:20 CEST Original file -
article xml uploaded. 16 September 2022 11:20 CEST Update https://www.mdpi.com/2072-6694/14/18/4492/xml
article pdf uploaded. 16 September 2022 11:20 CEST Version of Record https://www.mdpi.com/2072-6694/14/18/4492/pdf
article html file updated 16 September 2022 11:21 CEST Original file -
article html file updated 28 February 2023 13:54 CET Update https://www.mdpi.com/2072-6694/14/18/4492/html
Back to TopTop